{
    "Trade/Device Name(s)": [
        "MONOLISA\u2122 Anti-HAV IgM EIA",
        "MONOLISATM Anti-HAV IgM EIA",
        "MONOLISA\u2122M Anti-HAV IgM EIA"
    ],
    "Submitter Information": "Bio-Rad",
    "510(k) Number": "K063319",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL"
    ],
    "Summary Letter Date": "March 21, 2007",
    "Summary Letter Received Date": "April 3, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3310"
    ],
    "Regulation Name(s)": [
        "Hepatitis A Virus (HAV) Serological Reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "IgM antibodies to Hepatitis A Virus (anti-HAV IgM)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Citrate tube",
        "ACD tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Antibody capture format"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad MONOLISA\u2122 Anti-HAV IgM EIA enzyme immunoassay kit for qualitative detection of IgM antibodies to Hepatitis A virus in human serum and plasma",
    "Indications for Use Summary": "Qualitative detection of IgM antibodies to Hepatitis A virus (anti-HAV IgM) in human (adult and pediatric) serum or plasma for diagnosis of acute or recent Hepatitis A in individuals with signs and symptoms, not intended for donor screening",
    "fda_folder": "Microbiology"
}